Rituximab (anti-CD20)

Tax included
Rituximab (anti-CD20) is an anti-CD20 chimeric monoclonal antibody used to treat certain autoimmune diseases and types of cancer.
MedChemExpress 
HY-P9913A

Data sheet

Size
Multiple sizes
Reactivity
CD20
Application
COVID-19-immunoregulation
CAS
174722-31-7